Drug: temozolomide Quarter: 2016Q3
Total Records: 303 Number of Pages: 16
| DRUGNAME | PT | EventCount |
|---|---|---|
| TEMOZOLOMIDE. | Mass | 1 |
| TEMOZOLOMIDE. | Maternal exposure during pregnancy | 1 |
| TEMOZOLOMIDE. | Mental status changes | 1 |
| TEMOZOLOMIDE. | Microangiopathic haemolytic anaemia | 1 |
| TEMOZOLOMIDE. | Mucosal inflammation | 1 |
| TEMOZOLOMIDE. | Muscle spasms | 1 |
| TEMOZOLOMIDE. | Muscle twitching | 1 |
| TEMOZOLOMIDE. | Muscular weakness | 1 |
| TEMOZOLOMIDE. | Musculoskeletal pain | 1 |
| TEMOZOLOMIDE. | Myelodysplastic syndrome | 1 |
| TEMOZOLOMIDE. | Myositis | 1 |
| TEMOZOLOMIDE. | Neoplasm | 1 |
| TEMOZOLOMIDE. | Neoplasm progression | 1 |
| TEMOZOLOMIDE. | Nephropathy toxic | 1 |
| TEMOZOLOMIDE. | Nervous system disorder | 1 |
| TEMOZOLOMIDE. | Neuropathy peripheral | 1 |
| TEMOZOLOMIDE. | Nuclear magnetic resonance imaging brain abnormal | 1 |
| TEMOZOLOMIDE. | Off label use | 1 |
| TEMOZOLOMIDE. | Polyuria | 1 |
| TEMOZOLOMIDE. | Posterior reversible encephalopathy syndrome | 1 |
Total Records: 303 Number of Pages: 16